Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The Government scheme would benefit those aged under 40 but will only run for five years.
Joseph Rowntree Charitable Trust and the Roddick Foundation are under investigation by the watchdog over grants made to Cage.
The Duke of Cambridge became a fearsome samurai warlord - at least temporarily - when he visited the set of a long-running Japanese drama.